In December 2010 OWC conducted this exclusive interview with Dr. Burzynski on the results being experienced in his FDA Phase II cancer treatment studies using amino acid derived peptide drugs that target turning off identified cancer genes. This method is known as individualized gene targeted therapy and appears to be the future of high tech pharmacological medicine. Click here to view this exclusive and very exciting interview with Dr. Burzynski.
Dr. Burzynski discusses these major breakthroughs in this interview:
- his targeted drug discoveries kill malignant cancer cells without killing healthy cells
- his clinic’s results, even with advanced cancer patients, are today substantially better than the one size fits all model of drugs, radiation and surgery practiced by most cancer centers
- his medical facilities include over 20 doctors, a research facility and a drug manufacturing facility all in Texas
Unfortunately the FDA has not yet established a procedure for studying the effectiveness of integrative care (Click here to watch a video describing what integrative care and holistic medicine is).
Off camera Dr. Burzynski shared that his clinic has a very advanced integrative care model (except for those patients part of the FDA reviewed trials aimed to allow marketing of Dr. Burzynski’s new drugs as effective cancer fighting drugs).
The best results at the Burzynksi clinics and other advanced cancer treatment centers in the US and abroad are being obtained with integrative cancer therapies discussed in more detail in our Research library (click here to learn much more about advanced integrative cancer care).
Click here to view our exclusive and very exciting interview with Dr. Burzynski at the American Academy of Anti-Aging Medicine conference in December 2010.